DexCom ROE 2010-2024 | DXCM

Current and historical return on equity (ROE) values for DexCom (DXCM) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
DexCom ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $0.58B $2.10B 26.34%
2024-09-30 $0.68B $1.98B 31.21%
2024-06-30 $0.67B $2.43B 29.59%
2024-03-31 $0.64B $2.25B 29.43%
2023-12-31 $0.54B $2.07B 25.01%
2023-09-30 $0.38B $2.27B 17.31%
2023-06-30 $0.36B $2.10B 17.27%
2023-03-31 $0.29B $2.23B 13.88%
2022-12-31 $0.34B $2.13B 16.23%
2022-09-30 $0.24B $1.83B 11.74%
2022-06-30 $0.23B $2.26B 10.67%
2022-03-31 $0.26B $2.19B 12.29%
2021-12-31 $0.22B $2.04B 10.74%
2021-09-30 $0.63B $2.14B 32.20%
2021-06-30 $0.62B $2.00B 34.21%
2021-03-31 $0.59B $1.90B 35.61%
2020-12-31 $0.55B $1.83B 39.11%
2020-09-30 $0.23B $1.50B 19.78%
2020-06-30 $0.21B $1.35B 20.83%
2020-03-31 $0.15B $0.94B 18.10%
2019-12-31 $0.10B $0.88B 13.45%
2019-09-30 $-0.17B $0.76B -24.71%
2019-06-30 $-0.17B $0.69B -26.49%
2019-03-31 $-0.13B $0.67B -21.89%
2018-12-31 $-0.13B $0.66B -23.86%
2018-09-30 $0.04B $0.56B 9.34%
2018-06-30 $-0.01B $0.48B -1.17%
2018-03-31 $-0.03B $0.42B -8.11%
2017-12-31 $-0.05B $0.42B -13.94%
2017-09-30 $-0.05B $0.38B -14.77%
2017-06-30 $-0.07B $0.35B -22.07%
2017-03-31 $-0.09B $0.28B -32.90%
2016-12-31 $-0.07B $0.28B -25.42%
2016-09-30 $-0.06B $0.26B -23.33%
2016-06-30 $-0.08B $0.25B -35.91%
2016-03-31 $-0.06B $0.23B -31.37%
2015-12-31 $-0.06B $0.22B -31.61%
2015-09-30 $-0.06B $0.19B -36.14%
2015-06-30 $-0.02B $0.17B -14.61%
2015-03-31 $-0.02B $0.15B -18.25%
2014-12-31 $-0.02B $0.14B -20.67%
2014-09-30 $-0.03B $0.12B -27.76%
2014-06-30 $-0.03B $0.10B -32.09%
2014-03-31 $-0.03B $0.09B -39.88%
2013-12-31 $-0.03B $0.08B -39.34%
2013-09-30 $-0.04B $0.08B -46.98%
2013-06-30 $-0.05B $0.07B -60.73%
2013-03-31 $-0.05B $0.07B -63.35%
2012-12-31 $-0.05B $0.08B -62.07%
2012-09-30 $-0.06B $0.08B -61.70%
2012-06-30 $-0.05B $0.09B -52.81%
2012-03-31 $-0.05B $0.10B -41.82%
2011-12-31 $-0.04B $0.11B -44.78%
2011-09-30 $-0.04B $0.11B -48.14%
2011-06-30 $-0.04B $0.12B -61.99%
2011-03-31 $-0.05B $0.05B -98.95%
2010-12-31 $-0.06B $0.06B -119.57%
2010-09-30 $-0.06B $0.04B -217.14%
2010-06-30 $-0.06B $0.04B -380.33%
2010-03-31 $-0.06B $0.05B -1109.09%
2009-12-31 $-0.05B $-0.02B 2160.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $33.349B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $201.227B 88.14
Thermo Fisher Scientific (TMO) United States $163.300B 19.75
Alcon (ALC) Switzerland $46.755B 31.08
Edwards Lifesciences (EW) United States $43.878B 28.77
IDEXX Laboratories (IDXX) United States $40.977B 47.09
IQVIA Holdings (IQV) United States $27.010B 15.13
Mettler-Toledo (MTD) United States $24.411B 29.03
STERIS (STE) Ireland $22.902B 26.19
Waters (WAT) United States $21.820B 30.79
SONOVA HOLDING (SONVY) Switzerland $18.782B 0.00
Hologic (HOLX) United States $13.106B 14.24
Penumbra (PEN) United States $11.523B 90.44
Sysmex ADR (SSMXY) Japan $11.349B 0.00
Masimo (MASI) United States $8.868B 32.71
Globus Medical (GMED) United States $8.116B 19.03
Teleflex (TFX) United States $5.711B 9.43
Glaukos (GKOS) United States $5.408B 0.00
Integer Holdings (ITGR) United States $4.211B 22.07
TransMedics (TMDX) United States $4.016B 87.30
PROCEPT BioRobotics (PRCT) United States $3.012B 0.00
LivaNova (LIVN) United Kingdom $2.466B 14.69
Veracyte (VCYT) United States $2.409B 33.80
Nihon Kohden (NHNKY) Japan $2.072B 11.33
Elekta AB (EKTAY) Sweden $1.983B 17.83
Alphatec Holdings (ATEC) United States $1.852B 0.00
Tandem Diabetes Care (TNDM) United States $1.562B 0.00
Artivion (AORT) United States $1.229B 115.08
Pulse Biosciences (PLSE) United States $1.130B 0.00
Integra LifeSciences Holdings (IART) United States $1.062B 5.65
OPKO Health (OPK) United States $0.999B 0.00
SiBone (SIBN) United States $0.800B 0.00
Mesa Laboratories (MLAB) United States $0.696B 15.20
IRadimed (IRMD) United States $0.668B 33.92
Beta Bionics (BBNX) United States $0.615B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.606B 9.42
OrthoPediatrics (KIDS) United States $0.565B 0.00
RxSight (RXST) United States $0.559B 0.00
AxoGen (AXGN) United States $0.519B 0.00
Delcath Systems (DCTH) United States $0.503B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.485B 0.00
Treace Medical Concepts (TMCI) United States $0.452B 0.00
NeuroPace (NPCE) United States $0.438B 0.00
AngioDynamics (ANGO) United States $0.389B 0.00
ClearPoint Neuro (CLPT) United States $0.382B 0.00
Semler Scientific (SMLR) United States $0.334B 7.10
Pacific Biosciences Of California (PACB) United States $0.330B 0.00
Neuronetics (STIM) United States $0.273B 0.00
Tactile Systems Technology (TCMD) United States $0.226B 13.69
908 Devices (MASS) United States $0.205B 0.00
Alpha Tau Medical (DRTS) Israel $0.197B 0.00
Spectral Diagnostics (EDTXF) Canada $0.174B 0.00
Accuray (ARAY) United States $0.171B 0.00
Inogen (INGN) United States $0.169B 0.00
Sight Sciences (SGHT) United States $0.166B 0.00
LENSAR (LNSR) United States $0.165B 0.00
Anteris Technologies Global (AVR) Australia $0.163B 0.00
KORU Medical Systems (KRMD) United States $0.150B 0.00
Rapid Micro Biosystems (RPID) United States $0.126B 0.00
CVRx (CVRX) United States $0.124B 0.00
Lucid Diagnostics (LUCD) United States $0.116B 0.00
Atossa Genetics (ATOS) United States $0.108B 0.00
Monogram Orthopaedics (MGRM) United States $0.093B 0.00
Microbot Medical (MBOT) United States $0.089B 0.00
EDAP TMS S.A (EDAP) France $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.075B 11.38
EnVVeno Medical (NVNO) United States $0.063B 0.00
Hyperfine (HYPR) United States $0.057B 0.00
Biosig Technologies (BSGM) United States $0.053B 0.00
Vicarious Surgical (RBOT) United States $0.053B 0.00
Covalon Technologies (CVALF) Canada $0.050B 15.25
Envoy Medical (COCH) United States $0.036B 0.00
Baird Medical Investment Holdings (BDMD) $0.035B 0.00
Precision Optics (POCI) United States $0.035B 0.00
Spectral AI (MDAI) United States $0.034B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.021B 0.00
NexGel (NXGL) United States $0.021B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
WORK Medical Technology Group (WOK) China $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Accelerate Diagnostics (AXDX) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.06
Longview Acquisition II (LGV) United States $0.000B 0.00